List of works - Payam Nahid

A Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric Tuberculosis

scientific article

A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis

scientific article published on 27 November 2018

A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)

scientific article

A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis

scientific article published on 05 November 2018

Adaptation of Mycobacterium tuberculosis to Impaired Host Immunity in HIV-Infected Patients

scientific article published on 17 August 2016

Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies.

scientific article published on 3 July 2018

Advances in clinical trial design for development of new TB treatments: A call for innovation

article

Advances in clinical trial design: Weaving tomorrow's TB treatments

scientific article published on 27 February 2020

Advances in the diagnosis and treatment of tuberculosis.

scientific article published in January 2006

Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response.

scientific article published on 10 March 2012

Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis

article

Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis

scientific article

Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial

scientific article published on 24 October 2017

Challenges in the clinical assessment of novel tuberculosis drugs.

scientific article

Childhood tuberculosis in northern Viet Nam: a review of 103 cases

scientific article (publication date: 2014)

Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis.

scientific article published on 16 May 2017

Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis.

scientific article published on January 2009

Clinical practice. Latent tuberculosis infection

scientific article (publication date: 5 December 2002)

Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.

scientific article

Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials.

scientific article published on 25 January 2017

Detailed analysis of the radiographic presentation of Mycobacterium kansasii lung disease in patients with HIV infection.

scientific article published on 8 February 2008

Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MS

scientific article

Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance

scientific article published on 06 September 2019

Discriminating between latent and active tuberculosis with multiple biomarker responses.

scientific article

Does discovery of differentially culturable M tuberculosis really demand a new treatment paradigm? Longitudinal analysis of DNA clearance from sputum.

scientific article published on 3 July 2018

Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults.

scientific article published on March 2016

Evaluation of mobile digital light-emitting diode fluorescence microscopy in Hanoi, Viet Nam.

scientific article published on September 2015

Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

scientific article published on October 2016

Factors associated with failure to complete isoniazid therapy for latent tuberculosis infection in children and adolescents.

scientific article published on 19 December 2013

Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis.

scientific article

Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening

scientific article published on 30 May 2019

First in vivo magnetic particle imaging of lung perfusion in rats.

scientific article published on 20 February 2017

Hepatotoxicity in Children Receiving Isoniazid Therapy for Latent Tuberculosis Infection

scientific article

Impact of Euro-American sublineages of Mycobacterium tuberculosis on new infections among named contacts.

scientific article published on May 2017

Impact of isoniazid resistance-conferring mutations on the clinical presentation of isoniazid monoresistant tuberculosis

scientific article

In vitro immunomodulation for enhancing T cell-based diagnosis of Mycobacterium tuberculosis infection.

scientific article

Interplay of strain and race/ethnicity in the innate immune response to M. tuberculosis.

scientific article

Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape

scientific article published on 22 March 2019

Moving Toward Tuberculosis Elimination: Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection

scientific article published on 01 March 2019

Multidrug-resistant tuberculosis - Authors' reply

scientific article published on 01 July 2019

Mycobacterium tuberculosis lineage--what's in your lungs?

scientific article published in January 2012

Non-tuberculous mycobacterial infections at San Francisco General Hospital.

scientific article published on 6 May 2014

Novel hot spot of IS6110 insertion in Mycobacterium tuberculosis

scientific article

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

scientific article published on 10 August 2016

Prevention of tuberculosis in HIV-infected patients.

scientific article

Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model

scientific article

Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis

scientific article published on 01 January 2019

Pyrazinamide resistance, Mycobacterium tuberculosis lineage and treatment outcomes in San Francisco, California

scientific article (publication date: 2014)

Racial Differences in Tuberculosis Infection in United States Communities: The Coronary Artery Risk Development in Young Adults Study ⬇️

scientific article published on August 1, 2011

Reaching the limits of tuberculosis prevention among foreign-born individuals: a tuberculosis-control program perspective.

scientific article published in January 2008

Reply to: "ATS/CDC/ERS/IDSA Clinical Practice Guidelines for Treatment of Drug-resistant TB: A Two-edged Sword?"

scientific article published on 06 May 2020

Second generation multiple reaction monitoring assays for enhanced detection of ultra-low abundance Mycobacterium tuberculosis peptides in human serum.

scientific article

Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients

scientific article published on 18 April 2019

Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis.

scientific article published on 9 May 2015

Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis.

scientific article

Summary for Clinicians: 2019 Clinical Practice Guideline Summary for the Treatment of Drug-Resistant Tuberculosis

scientific article published on 28 May 2020

Target regimen profiles for treatment of tuberculosis: a WHO document.

scientific article

The association between Cytomegalovirus co-infection with Pneumocystis pneumonia and mortality in immunocompromised non-HIV patients

scientific article published on 01 November 2018

The continued hunt for the elusive standard short regimen for treatment of multidrug-resistant tuberculosis

scientific article published on 20 March 2020

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

scientific article

The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials

scientific article published on 10 December 2019

Towards tuberculosis elimination: an action framework for low-incidence countries

scientific article

Traffic-Related Air Pollution and All-Cause Mortality during Tuberculosis Treatment in California.

scientific article published on 29 September 2017

Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis

scientific article

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

scientific article published on 01 November 2019

Treatment of Drug-Susceptible Tuberculosis.

scientific article

Treatment of non-cavitary pulmonary tuberculosis with shortened fluoroquinolone-based regimens: a meta-analysis.

scientific article

Treatment outcomes of patients with HIV and tuberculosis.

scientific article published on 8 February 2007

Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.

scientific article

Update in tuberculosis and nontuberculous mycobacterial disease 2011.

scientific article published on June 2012

Update in tuberculosis and nontuberculous mycobacterial disease 2012.

scientific article published on October 2013

Vitamin D Deficiency in Patients Referred for Evaluation of Obstructive Sleep Apnea

scientific article published on 16 December 2016

Xpert MTB/RIF Assay Shows Faster Clearance of Mycobacterium tuberculosis DNA with Higher Levels of Rifapentine Exposure

scientific article published on 12 October 2016

List of works by Payam Nahid

A Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric Tuberculosis

A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis

A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)

A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis

Adaptation of Mycobacterium tuberculosis to Impaired Host Immunity in HIV-Infected Patients

Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies.

Advances in clinical trial design for development of new TB treatments: A call for innovation

Advances in clinical trial design: Weaving tomorrow's TB treatments

Advances in the diagnosis and treatment of tuberculosis.

Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response.

Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis

Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis

Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial

Challenges in the clinical assessment of novel tuberculosis drugs.

Childhood tuberculosis in northern Viet Nam: a review of 103 cases

Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis.

Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis.

Clinical practice. Latent tuberculosis infection

Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.

Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials.

Detailed analysis of the radiographic presentation of Mycobacterium kansasii lung disease in patients with HIV infection.

Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MS

Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance

Discriminating between latent and active tuberculosis with multiple biomarker responses.

Does discovery of differentially culturable M tuberculosis really demand a new treatment paradigm? Longitudinal analysis of DNA clearance from sputum.

Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults.

Evaluation of mobile digital light-emitting diode fluorescence microscopy in Hanoi, Viet Nam.

Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Factors associated with failure to complete isoniazid therapy for latent tuberculosis infection in children and adolescents.

Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis.

Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening

First in vivo magnetic particle imaging of lung perfusion in rats.

Hepatotoxicity in Children Receiving Isoniazid Therapy for Latent Tuberculosis Infection

Impact of Euro-American sublineages of Mycobacterium tuberculosis on new infections among named contacts.

Impact of isoniazid resistance-conferring mutations on the clinical presentation of isoniazid monoresistant tuberculosis

In vitro immunomodulation for enhancing T cell-based diagnosis of Mycobacterium tuberculosis infection.

Interplay of strain and race/ethnicity in the innate immune response to M. tuberculosis.

Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape

Moving Toward Tuberculosis Elimination: Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection

Multidrug-resistant tuberculosis - Authors' reply

Mycobacterium tuberculosis lineage--what's in your lungs?

Non-tuberculous mycobacterial infections at San Francisco General Hospital.

Novel hot spot of IS6110 insertion in Mycobacterium tuberculosis

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Prevention of tuberculosis in HIV-infected patients.

Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model

Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis

Pyrazinamide resistance, Mycobacterium tuberculosis lineage and treatment outcomes in San Francisco, California

Racial Differences in Tuberculosis Infection in United States Communities: The Coronary Artery Risk Development in Young Adults Study ⬇️

Reaching the limits of tuberculosis prevention among foreign-born individuals: a tuberculosis-control program perspective.

Reply to: "ATS/CDC/ERS/IDSA Clinical Practice Guidelines for Treatment of Drug-resistant TB: A Two-edged Sword?"

Second generation multiple reaction monitoring assays for enhanced detection of ultra-low abundance Mycobacterium tuberculosis peptides in human serum.

Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients

Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis.

Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis.

Summary for Clinicians: 2019 Clinical Practice Guideline Summary for the Treatment of Drug-Resistant Tuberculosis

Target regimen profiles for treatment of tuberculosis: a WHO document.

The association between Cytomegalovirus co-infection with Pneumocystis pneumonia and mortality in immunocompromised non-HIV patients

The continued hunt for the elusive standard short regimen for treatment of multidrug-resistant tuberculosis

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials

Towards tuberculosis elimination: an action framework for low-incidence countries

Traffic-Related Air Pollution and All-Cause Mortality during Tuberculosis Treatment in California.

Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

Treatment of Drug-Susceptible Tuberculosis.

Treatment of non-cavitary pulmonary tuberculosis with shortened fluoroquinolone-based regimens: a meta-analysis.

Treatment outcomes of patients with HIV and tuberculosis.

Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.

Update in tuberculosis and nontuberculous mycobacterial disease 2011.

Update in tuberculosis and nontuberculous mycobacterial disease 2012.

Vitamin D Deficiency in Patients Referred for Evaluation of Obstructive Sleep Apnea

Xpert MTB/RIF Assay Shows Faster Clearance of Mycobacterium tuberculosis DNA with Higher Levels of Rifapentine Exposure